Please check your mail in a few minutes for our welcome email and Free Report. If you do not see an email from us, please check your spam folder and add news@prostate.net to your approved/whitelist (or just click "not spam").

0

Follow Us: Follow Prostate on Facebook Follow ProstateNet on Twitter Follow Me on Pinterest

Beta-sitosterol Health Benefits

 
 
 
Browse Supplements | See All
Search in Top Supplements for Prostate Health (A-Z)

search this text  
 

Rate this Supplement:

1 Star2 Stars3 Stars4 Stars5 Stars (8 votes, average: 4.63 out of 5)
Loading ... Loading ...

Beta-sitosterol health benefits

Beta-sitosterol Health Benefits

Beta-sitosterol health benefits include an ability to treat and reduce symptoms of BPH, help with urinary and sexual health and possible help in fighting prostate cancer. Saw palmetto, which is used to treat BPH, and several other plants have been found to contain significant levels of beta-sitosterol.

Beta-sitosterol is a type of phytosterol (a plant-derived, cholesterol-like substance) found in a number of plants, including saw palmetto, rice bran, soybeans, pumpkin seed, peanuts, and pecans. Although beta-sitosterol has a structure similar to cholesterol, it does not act like cholesterol.

In fact, beta-sitosterol appears to act like the prescription drug finasteride (Proscar). Finasteride inhibits the activity of 5-alpha-reductase and is used to treat BPH. When beta-sitosterol is taken at high doses and along with other sterols, it has been shown to  reduce levels of total cholesterol and low-density lipoprotein (LDL) cholesterol. It accomplishes this by reducing the amount of cholesterol the body absorbs, which in turn may inhibit the production of dihydrotestosterone (DHT). There is also some evidence that beta-sitosterol health benefits include boosting immunity.

Beta-Sitosterol, BPH and Prostate Cancer

In a study published in Lancet, 200 men with BPH took 20 mg of beta-sitosterol or placebo three times a day for six months. At the end of six months, the researchers observed an increase in maximum urine flow rate from a baseline of 9.9 mL/second to 15.2 mL/second, as well as a decrease in mean residual urinary volume from 65.8 mL at baseline to 30.4 mL. No changes were reported in men who had taken placebo.  (Berges 1995)

After unblinding the 6 month trial from the previous Berges study (1995), men in both the beta-sitosterol and placebo groups  were given the option of staying on the trial for an additional 12 months while taking beta-sitosterol. A total of 117 men took 20 mg of beta-sitosterol three times a day.  In a follow-up study, the authors found that beta-sitosterol health benefits included the ability to maintain the advantages achieved previously for an additional 18 months of observation. (Berges 2000)

In 1997, a six-month double-blind, placebo-controlled clinical trial evaluated the efficacy and safety of 130 mg free beta-sitosterol compared with placebo in 177 men who had BPH. The International Prostate Symptom Score (IPSS) was the main outcome variable. Also evaluated were changes in qualify of life, peak urinary flow rate (Qmax), and post-void residual urinary volume. After six months, the researchers saw significant improvements in all factors over placebo in men who received beta-sitosterol. The authors concluded that “these results show that beta-sitosterol is an effective option in the treatment of BPH.”(Klippel 1997)

A subsequent review of all existing studies at that time (2000) of beta-sitosterol in men who had BPH was reported in Cochrane Databases of Systematic Reviews.. Four randomized, placebo-controlled, double-blind trials  that involved 519 men were evaluated. The investigators found that beta-sitosterols improved urinary symptom scores, peak urine flow, and residual volume. Beta-sitosterols did not reduce the size of the prostate. The reviewers concluded that beta-sitosterols “improve urinary symptoms and flow measures.” (Wilt 1999)

Beta-sitosterol health benefits have been noted in the area of prostate cancer, although limited. A study conducted in France showed that beta-sitosterol induced low growth inhibition on prostate cancer cells. (Jourdain 2006)

Taking Beta-sitosterol

When purchasing beta-sitosterol, make sure the supplement label clearly states the amount of beta-sitosterol in the product. If beta-sitosterol is just one of several plant sterols in the supplement, the beta-sitosterol should make up at least 50 percent of the total. Potential side effects include nausea, gas, and diarrhea.

To increase absorption, beta-sitosterol should be taken on an empty stomach. Typically it takes about four weeks to enjoy beta-sitosterol health benefits. The dosage can be reduced once symptoms improve. Consult a knowledgeable healthcare provider for more information on how to take advantage of beta-sitosterol health benefits.

Questions about Beta-sitosterol

Q. Dr. Geo. Great article about beta sitosterol, especially the advice to take it on an empty stomach to increase absorption when using it for BPH. Can you clarify information I have read saying I should look for products designed to treat BPH and not those for treating high cholesterol. Are the formulations different such that only the BPH formulation is well absorbed (as opposed to the cholesterol reducing formula which is designed to bind cholesterol in the gut and not be absorbed?

Kevin

A. Plant sterols (also known as stanols) supplements often contain ingredients other than beta-sitosterol, based on whether they are for BPH or for lowering cholesterol. For example,  beta-sitosterol supplement is targeted for BPH and prostate health while beta-sitosterol, along with all the other phytosterols (campesterol  campestanol, and sitostanol) are used combined to lower cholesterol. So if the primary goal is to obtain prostate health then a mixed phytosterol supplement with higher concentrations of  beta-sitosterol  levels (above 60 mg) should be used. Consumers should look at the amount of beta-sitosterol in the product and make sure they are getting the amount their healthcare provider recommends.

imagejpg
ADVERTISEMENT

References

Berges RR, Kassen A, Senge T. Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up. BJU Int 2000 May; 85(7):842-6.

Berges RR, Windeler J, Trampisch HJ, et al. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group. Lancet 1995; 345:1529-1532.

HealthLibrary: http://healthlibrary.epnet.com/GetContent.aspx?token=e0498803-7f62-4563-8d47-5fe33da65dd4&chunkiid=21555

Jourdain C et al. In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells. Eur J Cancer Prev 2006 Aug; 15(4): 353-61

Klippel KF, Hiltl DM, Schipp B. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group. Br J Urol 1997; 80:427-432.

Wilt TJ et al. A beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU Int 1999 Jun; 83(9): 976-83

*Medical Disclaimer

Created: September 18, 2010
ADVERTISEMENT

Site last updated 22 May, 2013

  
ZERO - The Project to End Prostate Cancer
  
Everyday Health
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the
HONcode standard for trustworthy
health
information: verify here.
Ad Choice
Advertising Notice

This Site and third parties who place advertisements on this Site may collect and use information about your visits to this Site and other websites in order to provide advertisements about goods and services of interest to you. If you would like to obtain more information about these advertising practices and to make choices about online behavioral advertising, please click here